
Montelukast (10mg) + Fexofenadine (120mg)
Active composition
+1 more active ingredient
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Fexofenadine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic reactions.
Medical applications
Fexolead-M Tablet is a combination medication containing Montelukast 10mg and Fexofenadine 120mg, designed to provide effective relief from allergic conditions. Montelukast is a leukotriene receptor antagonist that works by blocking substances called leukotrienes, which cause inflammation, bronchoconstriction, and mucus production in the airways. Fexofenadine is a second-generation antihistamine that selectively blocks peripheral H1 receptors, reducing symptoms such as sneezing, runny nose, itchy or watery eyes, and hives without causing significant drowsiness. Together, these active ingredients offer a comprehensive approach to managing allergic rhinitis, chronic urticaria, and other allergic manifestations by targeting multiple pathways involved in allergic responses. Fexolead-M is typically prescribed for patients who require both leukotriene receptor antagonism and antihistamine effects to control their symptoms effectively. It is important to take this medication as directed by a healthcare professional, usually once daily, preferably in the evening. Common side effects may include headache, dizziness, or gastrointestinal discomfort, but it is generally well tolerated. Patients with liver impairment or those taking other medications should consult their doctor before use. Fexolead-M Tablet is a valuable option for improving quality of life in individuals suffering from persistent allergic conditions.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Fexolead-M Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Fexolead-M Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Fexolead-M Tablet should be used with caution in patients with kidney disease. Dose adjustment of Fexolead-M Tablet may be needed. Please consult your doctor. May cause excessive sleepiness in patients with end stage kidney disease.
Exercise Caution
Fexolead-M Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Fexolead-M Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Fexolead-M Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Fexolead-M Tablet

Montelukast (10mg) + Fexofenadine (120mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Fexofenadine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic reactions.
Medical applications
Fexolead-M Tablet is a combination medication containing Montelukast 10mg and Fexofenadine 120mg, designed to provide effective relief from allergic conditions. Montelukast is a leukotriene receptor antagonist that works by blocking substances called leukotrienes, which cause inflammation, bronchoconstriction, and mucus production in the airways. Fexofenadine is a second-generation antihistamine that selectively blocks peripheral H1 receptors, reducing symptoms such as sneezing, runny nose, itchy or watery eyes, and hives without causing significant drowsiness. Together, these active ingredients offer a comprehensive approach to managing allergic rhinitis, chronic urticaria, and other allergic manifestations by targeting multiple pathways involved in allergic responses. Fexolead-M is typically prescribed for patients who require both leukotriene receptor antagonism and antihistamine effects to control their symptoms effectively. It is important to take this medication as directed by a healthcare professional, usually once daily, preferably in the evening. Common side effects may include headache, dizziness, or gastrointestinal discomfort, but it is generally well tolerated. Patients with liver impairment or those taking other medications should consult their doctor before use. Fexolead-M Tablet is a valuable option for improving quality of life in individuals suffering from persistent allergic conditions.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Fexolead-M Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Fexolead-M Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Fexolead-M Tablet should be used with caution in patients with kidney disease. Dose adjustment of Fexolead-M Tablet may be needed. Please consult your doctor. May cause excessive sleepiness in patients with end stage kidney disease.
Exercise Caution
Fexolead-M Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Fexolead-M Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Fexolead-M Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Fexolead-M Tablet















